Iatrogenic hyperinsulinemia in type 1 diabetes

Its effect on atherogenic risk markers

May-Yun Wang, Xinxin Yu, Young H Lee, S. Kay McCorkle, Gregory O. Clark, Suzanne Strowig, Roger H Unger, Philip Raskin

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Aims: Insulin is lipogenic and may invoke inflammation. We wished to determine if well controlled human and mice with type 1 diabetes had iatrogenic hyperinsulinemia as an explanation for the increased rate of coronary artery disease (CAD) in type 1 diabetes. Methods: Type 1 diabetic subjects with HbA1C less than 7.0% had plasma insulin measured before and one hour after a Boost® challenge and a dose of subcutaneously administered insulin. These levels were compared with non-diabetic humans. Plasma insulin levels in well controlled NOD mice with type 1 diabetes were measured 3 h and 17 h after their usual dose of insulin. Hepatic cholesterol-relevant CAD and inflammation markers were measured in the NOD mice. Result: Marked iatrogenic hyperinsulinemia was observed in patients at levels of approximately two times higher than in non-diabetic controls. Similar findings were present in the NOD mice. Hepatic CAD risk markers were increased by insulin, but did not exceed normal expression levels in non-diabetic mice with lower insulin. In contrast, insulin-mediated stimulation of pro-inflammatory mediators TNF-α and IL-1β remained significantly higher in hyperinsulinemic NOD than non-diabetic mice. Conclusion: Optimal insulin therapy in mice and humans with type 1 diabetes causes iatrogenic hyperinsulinemia and subsequently promotes pro-inflammatory macrophage response independent of hepatic cholesterol-relevant CAD markers. The tight glycemic control in type 1 diabetes may thus increase the risk for atherogenesis via inflammation.

Original languageEnglish (US)
Pages (from-to)70-74
Number of pages5
JournalJournal of Diabetes and its Complications
Volume27
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Hyperinsulinism
Type 1 Diabetes Mellitus
Insulin
Inbred NOD Mouse
Coronary Artery Disease
Inflammation
Cholesterol
Liver
Hepatic Artery
Interleukin-1
Atherosclerosis
Macrophages

Keywords

  • Coronary artery disease
  • Iatrogenic hyperinsulinemia
  • Type 1 diabetes

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Iatrogenic hyperinsulinemia in type 1 diabetes : Its effect on atherogenic risk markers. / Wang, May-Yun; Yu, Xinxin; Lee, Young H; McCorkle, S. Kay; Clark, Gregory O.; Strowig, Suzanne; Unger, Roger H; Raskin, Philip.

In: Journal of Diabetes and its Complications, Vol. 27, No. 1, 01.2013, p. 70-74.

Research output: Contribution to journalArticle

@article{377efe76b29f4d92a82382f5ca6f900e,
title = "Iatrogenic hyperinsulinemia in type 1 diabetes: Its effect on atherogenic risk markers",
abstract = "Aims: Insulin is lipogenic and may invoke inflammation. We wished to determine if well controlled human and mice with type 1 diabetes had iatrogenic hyperinsulinemia as an explanation for the increased rate of coronary artery disease (CAD) in type 1 diabetes. Methods: Type 1 diabetic subjects with HbA1C less than 7.0{\%} had plasma insulin measured before and one hour after a Boost{\circledR} challenge and a dose of subcutaneously administered insulin. These levels were compared with non-diabetic humans. Plasma insulin levels in well controlled NOD mice with type 1 diabetes were measured 3 h and 17 h after their usual dose of insulin. Hepatic cholesterol-relevant CAD and inflammation markers were measured in the NOD mice. Result: Marked iatrogenic hyperinsulinemia was observed in patients at levels of approximately two times higher than in non-diabetic controls. Similar findings were present in the NOD mice. Hepatic CAD risk markers were increased by insulin, but did not exceed normal expression levels in non-diabetic mice with lower insulin. In contrast, insulin-mediated stimulation of pro-inflammatory mediators TNF-α and IL-1β remained significantly higher in hyperinsulinemic NOD than non-diabetic mice. Conclusion: Optimal insulin therapy in mice and humans with type 1 diabetes causes iatrogenic hyperinsulinemia and subsequently promotes pro-inflammatory macrophage response independent of hepatic cholesterol-relevant CAD markers. The tight glycemic control in type 1 diabetes may thus increase the risk for atherogenesis via inflammation.",
keywords = "Coronary artery disease, Iatrogenic hyperinsulinemia, Type 1 diabetes",
author = "May-Yun Wang and Xinxin Yu and Lee, {Young H} and McCorkle, {S. Kay} and Clark, {Gregory O.} and Suzanne Strowig and Unger, {Roger H} and Philip Raskin",
year = "2013",
month = "1",
doi = "10.1016/j.jdiacomp.2012.08.008",
language = "English (US)",
volume = "27",
pages = "70--74",
journal = "Journal of Diabetes and its Complications",
issn = "1056-8727",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Iatrogenic hyperinsulinemia in type 1 diabetes

T2 - Its effect on atherogenic risk markers

AU - Wang, May-Yun

AU - Yu, Xinxin

AU - Lee, Young H

AU - McCorkle, S. Kay

AU - Clark, Gregory O.

AU - Strowig, Suzanne

AU - Unger, Roger H

AU - Raskin, Philip

PY - 2013/1

Y1 - 2013/1

N2 - Aims: Insulin is lipogenic and may invoke inflammation. We wished to determine if well controlled human and mice with type 1 diabetes had iatrogenic hyperinsulinemia as an explanation for the increased rate of coronary artery disease (CAD) in type 1 diabetes. Methods: Type 1 diabetic subjects with HbA1C less than 7.0% had plasma insulin measured before and one hour after a Boost® challenge and a dose of subcutaneously administered insulin. These levels were compared with non-diabetic humans. Plasma insulin levels in well controlled NOD mice with type 1 diabetes were measured 3 h and 17 h after their usual dose of insulin. Hepatic cholesterol-relevant CAD and inflammation markers were measured in the NOD mice. Result: Marked iatrogenic hyperinsulinemia was observed in patients at levels of approximately two times higher than in non-diabetic controls. Similar findings were present in the NOD mice. Hepatic CAD risk markers were increased by insulin, but did not exceed normal expression levels in non-diabetic mice with lower insulin. In contrast, insulin-mediated stimulation of pro-inflammatory mediators TNF-α and IL-1β remained significantly higher in hyperinsulinemic NOD than non-diabetic mice. Conclusion: Optimal insulin therapy in mice and humans with type 1 diabetes causes iatrogenic hyperinsulinemia and subsequently promotes pro-inflammatory macrophage response independent of hepatic cholesterol-relevant CAD markers. The tight glycemic control in type 1 diabetes may thus increase the risk for atherogenesis via inflammation.

AB - Aims: Insulin is lipogenic and may invoke inflammation. We wished to determine if well controlled human and mice with type 1 diabetes had iatrogenic hyperinsulinemia as an explanation for the increased rate of coronary artery disease (CAD) in type 1 diabetes. Methods: Type 1 diabetic subjects with HbA1C less than 7.0% had plasma insulin measured before and one hour after a Boost® challenge and a dose of subcutaneously administered insulin. These levels were compared with non-diabetic humans. Plasma insulin levels in well controlled NOD mice with type 1 diabetes were measured 3 h and 17 h after their usual dose of insulin. Hepatic cholesterol-relevant CAD and inflammation markers were measured in the NOD mice. Result: Marked iatrogenic hyperinsulinemia was observed in patients at levels of approximately two times higher than in non-diabetic controls. Similar findings were present in the NOD mice. Hepatic CAD risk markers were increased by insulin, but did not exceed normal expression levels in non-diabetic mice with lower insulin. In contrast, insulin-mediated stimulation of pro-inflammatory mediators TNF-α and IL-1β remained significantly higher in hyperinsulinemic NOD than non-diabetic mice. Conclusion: Optimal insulin therapy in mice and humans with type 1 diabetes causes iatrogenic hyperinsulinemia and subsequently promotes pro-inflammatory macrophage response independent of hepatic cholesterol-relevant CAD markers. The tight glycemic control in type 1 diabetes may thus increase the risk for atherogenesis via inflammation.

KW - Coronary artery disease

KW - Iatrogenic hyperinsulinemia

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84872500342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872500342&partnerID=8YFLogxK

U2 - 10.1016/j.jdiacomp.2012.08.008

DO - 10.1016/j.jdiacomp.2012.08.008

M3 - Article

VL - 27

SP - 70

EP - 74

JO - Journal of Diabetes and its Complications

JF - Journal of Diabetes and its Complications

SN - 1056-8727

IS - 1

ER -